Bronchoscopy During COVID-19 Webinar Series
Watch our 4-part, educational webinar series, Bronchoscopy During COVID-19, where we look at the lessons learned during the first few months of the pandemic; changes in bronchoscopy procedures to protect the patient and the healthcare worker; and guidelines for future care.
At the start of the pandemic in the U.S., the American Association for Bronchology and Interventional Pulmonology (AABIP) issued guidelines that physicians should use a disposable bronchoscope to protect patients and staff if the procedure was warranted for COVID-19 testing or treatment. Otherwise, AABIP recommended physicians not perform bronchoscopies on COVID-19 patients, despite upper respiratory sampling being a primary method of diagnosing the novel virus.
What guidelines are recommended for the future? How do we protect healthcare workers? How have some hospitals continued bronchoscopy procedures, all while keeping a safe working environment? Our experts discuss these topics and more during each webinar, along with Q&A time provided to registered attendees.
COVID-19 in New York: Real Life Experiences
Featuring Dr. James Horowitz; Moderated by Dr. Oren Friedman
Watch Now
Performing Bronchoscopy in Times of COVID-19: Review of International Expert Panel Practice Statement
Featuring Dr. Angela Argento and Dr. Elizabeth Malsin
Protecting Patients and Healthcare Providers During Challenging Times: Evidence-Based Recommendations to Reduce Risks with Bronchoscopy
Featuring Dr. Hudson Garrett
Watch Now
Health Economics: Comparing the Costs of Reusable vs. Single-Use Bronchoscopes
Featuring Russ Montgomery, PhD
COVID-19 in New York: Real Life Experiences
Webinar from Thursday, August 13, 7:00pm EDT
Dr. James M. Horowitz discusses his experiences performing bronchoscopy on COVID-19 patients at NYU as the novel coronavirus swept through New York City in the spring. In a discussion moderated by Dr. Oren Friedman, Dr. Horowitz details patient care and outcomes, best practices for healthcare provider safety, and how to safely utilize bronchoscopy to treat expected future waves of COVID-19 hospitalizations.
Dr. Horowitz is a cardiology specialist affiliated with NewYork-Presbyterian/Weill Cornell Medical Center and NYU Langone Health Tisch Hospital. He graduated from the University of Pennsylvania School of Medicine in 2005.
Dr. Friedman is the associate director of cardiac surgery in the Smidt Heart Institute intensive care unit at Cedars-Sinai Medical Center. He graduated from the Tufts University School of Medicine in 2003.
Performing Bronchoscopy in Times of COVID-19: Review of International Expert Panel Practice Statement
Webinar from Thursday, August 20, 7:00pm EDT
Dr. Angela Argento and Dr. Elizabeth Malsin discuss recommendations from a recent bronchoscopy practice statement published in Respiration developed by an expert panel of international practitioners. The practice statement provided practical bronchoscopy recommendations for protecting patient and clinician during the COVID-19 pandemic.
Dr. Argento is the director of interventional pulmonary at Northwestern University, Feinberg School of Medicine. She graduated from St. George’s University School of Medicine in 2005.
Dr. Malsin is a pulmonary critical care specialist at Northwestern Memorial Hospital. She graduated from the Drexel University College of Medicine in 2011.
Protecting Patients and Healthcare Providers During Challenging Times: Evidence-Based Recommendations to Reduce Risks with Bronchoscopy
Webinar from Wednesday, August 26, 7:00p.m. EDT
Dr. Hudson Garrett details best-practice guidelines for how to protect healthcare providers and patients during bronchoscopy. Dr. Garrett has closely monitored and addressed the challenges associated with procedures during the COVID-19 global pandemic, both through his direct clinical experience in caring for COVID-19 patients and close collaboration with international infectious disease experts such as the CDC. Among the most alarming risks to the healthcare team is the aerosols generated by bronchoscopy, which can be especially prevalent during bedside bronchoscopy, where there is normally little ventilation and increased risk during the challenges of the COVID-19 pandemic. Dr. Garrett highlights such clinical guidelines as placing the patient in an airborne infection isolation room and using a sustainable strategy for eye protection to ensure adequate protection of the healthcare team.
Dr. Garrett is an international expert in infection prevention and control, infectious diseases, patient safety, and medical device safety and hygiene. Currently, he serves as the president and CEO of Community Health Associates LLC and is an adjunct assistant professor of medicine at the University of Louisville School of Medicine Division of Infectious Diseases.
He previously served as the global chief clinical officer for Pentax Medical and spent more than a decade as the vice president of clinical affairs for PDI Healthcare. Dr. Garrett co-founded the Infection Prevention Institute, which shares the latest in evidence-based practices of infection prevention and control globally.
Health Economics: Comparing the Costs of Reusable vs. Single-Use Bronchoscopes
Webinar from Monday, August 31, 7:00pm EDT
In the battle for bronchoscopy, which brings more value — reusable or single-use bronchoscopes? Russ Montgomery, Director of Health Economics and Market Access for Ambu Inc., reveals the true cost of reusable bronchoscopes by reviewing all the cost drivers – not just the scopes, but also reprocessing, repairs, and treating infections resulting from cross-contamination. In the end, Montgomery makes the case for why moving to single-use bronchoscopy not only reduces risks to patient safety, but also saves money and reduces financial risk in this time of economic uncertainty.
Russ Montgomery, PhD, is the Director of Health Economics and Market Access for North America at Ambu, Inc. In this role, Montgomery is responsible for research and analysis to demonstrate the value of Ambu’s single-use endoscopes and the execution of strategies to achieve broad market access. Previously, Montgomery was a Vice President at Discern Health, responsible for outcomes research, cost analyses, value communication, and market access strategy for pharmaceutical and device manufacturers. In previous positions, Montgomery worked for various state and federal health agencies, including the Maryland Department of Health and Centers for Medicare & Medicaid Services. He earned his doctorate degree in Health Services Research and Policy in 2015 from the Johns Hopkins University Bloomberg School of Public Health, where he concentrated on quantitative research methods and health technology assessment. He also holds a Master of Health Science in Health Policy from Johns Hopkins and a Bachelor of Arts degree in Political Science from Hendrix College.
